Baroreflex sensitivity and the blood pressure response to -blockade
|
|
- Earl Powell
- 5 years ago
- Views:
Transcription
1 Journal of Human Hypertension (1999) 13, Stockton Press. All rights reserved /99 $ ORIGINAL ARTICLE Baroreflex sensitivity and the blood pressure response to -blockade X Chen, MO Hassan, JV Jones, P Sleight and JS Floras Department of Cardiovascular Medicine, University of Oxford, and Centre for Cardiovascular Research, University of Toronto, Canada The objective of this analysis was to determine whether changes in baroreflex sensitivity (BRS) within 35 hypertensive patients (25 M, 10 F, mean age 47 years) treated with -blockade as monotherapy relate to reductions in ambulatory blood pressure (BP) or its variability. BP was recorded intra-arterially directly from the brachial artery before and during submaximal exercise. BRS was determined by the phenylephrine injection technique. MAP and its variability were determined for the awake period of 24-h BP monitoring. Subjects were randomised to one of atenolol, metoprolol, pindolol, or propranolol, and restudied after a mean of 5 months. -blockade increased BRS in 24 patients and decreased BRS in 11. BRS increased from to ms/mm Hg (mean s.d.) (P 0.01). Waking ambulatory MAP decreased from to mm Hg (P ), but its variability did not change. Higher BRS after chronic -blockade was associated with a decrease in waking ambulatory MAP (r 0.55, P 0.001), but not with its variability (r 0.08). blockade attenuated the pressor response to exercise, but there was a positive relationship between the effect of -blockade on BRS, and on the rise in systolic BP during bicycling (r 0.63; P 0.001). Any dampening effect of -blockade on BP variability at rest in hypertensive patients with the greatest increase in BRS may be offset by increased pressor responses to physical activity such as exercise. Consequently, BP variability is unaffected, even though reductions in ambulatory BP during chronic -blockade are inversely related to changes in BRS. BP responses to -blockade may be a function of the action of this class of drugs on BRS. However, there is considerable variation, between subjects, in their effect on BRS. This may have implications for other conditions, such as dilated cardiomyopathy, or following myocardial infarction, in which improvement in BRS is one mechanism by which -adrenoceptor blockade could improve survival. Keywords: ambulatory blood pressure; baroreflex sensitivity for heart rate; -adrenoceptor blockade; blood pressure variability; exercise; hypertension Introduction There is considerable variation between hypertensive patients in the blood pressure (BP) response to -adrenoceptor blockade. Hypertensive patients also vary with respect to the effect of chronic -adrenoceptor blockade on baroreflex sensitivity (BRS) for heart rate. 1 6 The purpose of the present analysis was to determine if these two observations are related. We have previously reported that the arterial baroreflex regulation of heart rate is impaired in patients with essential hypertension, 7 and that this diminished arterial baroreceptor reflex is associated with increased variability of ambulatory BP and augmented BP responses to mental and physical activities. 8 After chronic -blockade using both cardioselective and non-selective drugs, mean arterial ambulatory BP was significantly decreased, 9 the mean baroreflex sensitivity was significantly increased, 1 and the pressor response to exercise was Correspondence: Dr John S Floras, Division of Cardiology, Room 1614, Mount Sinai Hospital, 600 University Avenue, Toronto, Ontario, Canada M5G 1X5 Received 11 November 1998; revised and accepted 17 December 1998 attenuated. 9 However, there was considerable difference between individuals in the effect of chronic blockade on BP and on baroreflex sensitivity, increasing in some, and decreasing in others. Moreover, the functional implications of these changes in individual subjects, with respect to ambulatory BP and its variability, have not been reported. In a recent publication, Vesalainen et al 2 contrasted the effects of 4 weeks of monotherapy with metoprolol and ramipril on heart rate variability, baroreflex sensitivity, and ambulatory BP. Both drugs caused comparable reductions in ambulatory BP, but only metoprolol increased baroreflex sensitivity, and cardiac vagal activity, as assessed by heart rate, heart rate variability, and the high frequency component of heart rate variability during supine rest. Reductions in ambulatory BP correlated significantly with increases in RR interval, its total variability, and high frequency variability. However, there was no significant relationship between changes in baroreflex sensitivity and ambulatory BP in these patients. We undertook the present re-analysis of our original data set to determine whether improvement in arterial baroreflex sensitivity for heart rate, with chronic -adrenoceptor blockade, will result in correspondingly lower ambulatory BP, or BP varia-
2 186 -blockade, baroreflex sensitivity, and BP bility, or attenuated BP responses to submaximal exercise in hypertensive patients. Because it is now recognised that 24-h ambulatory BP and BP variability are more closely related to end-organ damage in hypertension than is the office BP measurement, and that increased BP variability is an independent adverse risk factor for greater vascular and target organ damage, 10,13 this question now has clinical relevance. Subjects and methods Details of the study protocol have been published. 1,7 9 Observations in 35 subjects (25 males, 10 females) referred for the assessment of newly diagnosed, untreated hypertension are reported. Subjects ranged from 16 to 69 years old, with a mean age of 47 (s.d. 12) years. Blood pressure was measured on three or more clinic visits using a standard mercury sphygmomanometer. For the purpose of this study, patients were considered hypertensive when their clinic BP was 140/90 mm Hg or greater, if less than 40 years old, or at or above 160/95 mm Hg, if 40 years or older. Subjects with secondary hypertension were excluded. The study protocol was approved by the Hospital Ethics Committee and informed, written consent was obtained from each subject. Protocol Subjects were studied in the morning after a light breakfast at home, avoiding tea, coffee, or cigarettes. Arterial BP was recorded from a left brachial artery cannula, and an adjacent antecubital vein was also cannulated for injection of phenylephrine. ECG (lead II) and intra-arterial BP were recorded continuously for 24 h 7,8 and digitised for computer analysis. Baroreflex sensitivity was measured during supine rest, using the phenylephrine method. 7,8 Subjects performed a submaximal bicycle exercise test, 8,9 then left hospital to resume routine activities, and kept a diary noting, in particular, times of sleep and waking. Because the frequency response of the entire ambulatory recording and replay system falls off rapidly above 10 Hz, 14 we used mean, rather than systolic, BP in these calculations. Average awake mean arterial pressure (MAP) was computed using all valid beats over this period. Blood pressure variability was defined as the standard deviation of the waking mean arterial pressures. 7,8 After the first study, subjects were randomised to one of four adrenergic receptor blocking drugs: atenolol (n=9), metoprolol (n = 9), pindolol (n = 9), or slow-release propranolol (n=8). All drugs were taken once daily, in the morning, for 3 to 8 months (mean: 5 months). 1,9 Subjects were evaluated at monthly intervals at the same time of the day, and the medication dose adjusted if a cuff BP of 140/90 mm Hg or less was not achieved. The study protocol was replicated while on chronic treatment, with the last tablet taken at am on the morning of the second study. Statistics Data are presented as mean ± standard deviation. Values for baroreflex sensitivity were logarithmically transformed to approximate a normal distribution. Student s t-test was used for paired data when comparing control versus treatment days. P values 0.05 were considered statistically significant. Results Chronic -adrenoceptor blockade increased baroreflex sensitivity in 24 subjects, and decreased it in 11. Patients whose BRS increased tended to be younger (45.6 ± 12.4 vs 50.6 ± 10.9 years), and comprised eight of the 10 women, but these age and sex distributions were not significantly different between the two groups. The average ambulatory mean arterial pressures (126 mm Hg) and heart rates (89 bpm) were identical in the two groups, and the number of patients in whom BRS increased was similar for each drug. Mean values were significantly augmented, from 6.53 ± 4.94 msec/mm Hg before, to 9.40 ± 8.62 msec/mm Hg during -adrenoceptor blockade (P 0.01). Corresponding values for the Log transformation of baroreflex sensitivity were ± and ± respectively (P 0.02). Paired data were available for analysis of ambulatory BP in 34 patients. As demonstrated in Table 1, adrenoceptor blockade reduced significantly MAP, from ± 15.8 to ± 16.2 mm Hg (P ). -blockade had no effect on the variability of MAP (14.8 ± 4.1 mm Hg untreated vs 15.0 ± 3.2 mm Hg on treatment). The coefficient of variation increased, from 11.9 ± 2.9% to 14.3 ± 3.2% (P 0.002). Increases in Log (BRS) were inversely related to reductions in ambulatory mean arterial pressure (r = 0.55, P 0.001) (Figure 1). As illustrated in Figure 2, there was no relationship between these changes in Log BRS and changes in the variability of mean arterial pressure, as a result of treatment (r = 0.08). Paired data were available for analysis of BP during exercise in 33 patients. Chronic -adrenoceptor blockade attenuated significantly the increase in BP during bicycle exercise. Systolic BP increased by 59.6 ± 18.5 mm Hg before, and 42.5 ± 20.2 mm Hg after, -blockade (P 0.05), while diastolic BP rose by 17.7 ± 9.4 mm Hg before and by 14.7 ± 9.1 mm Hg after -blockade (P 0.05). There was a positive linear relationship between increases in Log (BRS) on chronic -adrenoceptor blockade and changes in the systolic BP response to bicycle exercise (Figure 3, r = 0.63, P 0.001). Discussion The purpose of this re-analysis was to determine if increases in arterial baroreflex sensitivity for heart rate with chronic -blockade relate to reductions in ambulatory BP, BP variability, or blunted BP responses to bicycle exercise. There are several
3 -blockade, baroreflex sensitivity, and BP Table 1 Effects of chronic -adrenergic blockade on arterial baroreflex sensitivity, ambulatory blood pressure and its variability 187 Variable Pre -blockade -blockade Difference Ambulatory blood pressure MAP (mm Hg) ± ± ± 14.8*** Variability (mm Hg) 14.8 ± ± ± 4.7 CV (%) 11.9 ± ± ± 4.0** Baroreflex sensitivity BRS (ms/mm Hg) 6.53 ± ± ± 5.88* Log (BRS) ± ± ± Mean ± s.d. MAP; mean arterial blood pressure, CV; coefficient of variance, BRS; baroreflex sensitivity. + P 0.02, *P 0.01, **P 0.002, ***P Figure 1 Relationship between changes in arterial baroreflex sensitivity for heart rate (Log (BRS)) and changes in ambulatory awake mean arterial blood pressure after chronic -adrenoceptor blockade (n = 34, r = 0.55, P 0.001). unique aspects to this analysis that distinguish these findings from other reports. Blood pressure was measured directly, using intra-arterial ambulatory monitoring, and baroreflex sensitivity measured directly, using the phenylephrine technique. Only those BP data obtained when subjects were awake and active were included. Patients were studied after long-term treatment (on average 5 months) and, as the recordings were done approximately 5 h after taking the last dose of the drug, the effects of chronic, rather than the acute-on-chronic effect, of -blockade were assessed. Increased baroreflex sensitivity for heart rate following chronic -blockade in the present study was associated with reduced ambulatory BP. This finding contrasts with the smaller series of Vesalainen et al, 2 who restricted their study to metoprolol. Those authors demonstrated an inverse relationship between changes in ambulatory BP, and indices of cardiac vagal activity based on heart rate variability, but did not detect an inverse relationship between changes in baroreflex sensitivity and ambulatory BP. Despite the fall in average ambulatory BP, increased baroreflex sensitivity was not accompanied by attenuation of blood pressure variability, or by a blunting of the pressor response to exercise. Our principal observation cannot be explained as a non-specific response to reductions in BP with treatment. In a few of our patients (Figure 1), a reduction in awake ambulatory BP was observed in conjunction with a decrease in baroreflex sensitivity. Diuretics, angiotensin-converting enzyme inhibitors and calcium channel antagonists lower BP equally well, but they do not appear to increase baroreflex sensitivity consistently. 2,15 22 For example, in previous reports, captopril increased
4 -blockade, baroreflex sensitivity, and BP 188 Figure 2 Absence of relationship between changes in arterial baroreflex sensitivity for heart rate (Log (BRS)) and changes in the variability of ambulatory awake arterial blood pressure (n = 34, r = 0.08, P 0.6). Figure 3 Relationship between changes in arterial baroreflex sensitivity for heart rate (Log (BRS)) and the effect of chronic -adrenoceptor blockade on the rise in systolic blood pressure during bicycle exercise (n = 33, r =+0.63, P 0.001).
5 baroreflex sensitivity in normotensive and hypertensive humans, 15,16 and lisinopril in elderly hypertensives, 17 whereas ramipril, in a dose therapeutically equal to metoprolol, had no such effect. 2 There are conflicting reports on the effects of calcium channel antagonists on baroreflex sensitivity In contrast to the present analysis, neither of those studies, nor other studies of short-term treatment with -adrenoceptor antagonists 3,4 addressed the functional implications of these observations with respect to changes in ambulatory BP or its variability within individual subjects. When we first reported group mean data from this cohort, 1,7 we attempted to relate changes in baroreflex sensitivity to changes in systolic BP at the time of the phenylephrine injection, 1 but we did not specifically address the question as to whether changes in baroreflex sensitivity within subjects might determine the ambulatory BP response to blockade. However, recent developments prompted the analysis of these data, in the present form, with the goal of stimulating hypotheses for testing in future studies. For example, there has been increasing recognition of the importance of ambulatory BP monitoring and BP variability, as risk factors for end-organ damage in hypertension, and increased BP variability is now recognised as an independent adverse risk factor for greater vascular and target organ damage Reduced baroreflex sensitivity following myocardial infarction is now known to be an important risk factor for premature mortality. 23 Whether increasing baroreflex sensitivity pharmacologically will improve prognosis has not been determined, but the benefits of chronic adrenoceptor blockade, when given following myocardial infarction, have been well established 24 and there is increasing interest in the administration of -adrenoceptor blockade to patients with left ventricular dysfunction. 25 There is considerable variation between patients in the BP response to -blockade, and the mechanism by which -adrenoceptor antagonism reduces BP remains obscure. Our data, which are derived from the entire ambulatory recording during the awake period, argue for a potential relationship between this hypotensive action, and augmented baroreflex sensitivity for heart rate. If so, this may be mediated at the level of the arterial baroreceptor afferents. 26 Long-term -adrenoceptor blockade also reduces central sympathetic outflow. 27 Thus, there may be two mechanisms by which the -adrenoceptor blockade could cause the vagal control of heart rate to predominate: a reduction in sympathetic traffic to cardiac nerves, and reduction in the normal sympathetic antagonism of vagal effects at the sinoatrial node. 28 If the BP response to -adrenoceptor blockade is indeed a function of changes in baroreflex sensitivity, future studies might focus on the reasons for the variability between subjects of the effects of blockade on the baroreflex control of heart rate. One factor may be the duration of hypertension that has elapsed prior to the initiation of treatment. When given to rats early in the course of spontaneous hypertension, atenolol increased the gain of the -blockade, baroreflex sensitivity, and BP baroreceptor reflex control of renal sympathetic nerve activity, and of heart rate, whereas, when given late in the course of spontaneous hypertension, these effects of atenolol were lost. 29 The authors of this experimental study suggested that there may be a critical phase representing the optimal time to initiate antihypertensive treatment. 29 A second factor may be patient age. It has been proposed that increases in BRS with chronic -adrenoceptor blockade occur primarily in younger hypertensives, 5,6 possibly due to alterations in compliance of the arterial conduits that house arterial baroreceptor afferents, or due to an age-related decrease in cardiac muscarinic receptor responsiveness. 30 Subjects whose BRS decreased tended to be older, in the present study, but this difference was not significant. We did not address the issue of how these changes in baroreflex sensitivity relate to changes in central and peripheral haemodynamics at rest, and during bicycle exercise, or the influence of these drugs on sympathetic nerve traffic to the heart and periphery. In the absence of such information, we can only speculate as to why there was a direct relationship between changes in baroreflex sensitivity and changes in systolic BP during bicycle exercise. For example, pulse pressure may have increased to compensate for a blunted heart rate response to exercise. These novel observations suggest that the antihypertensive action of -blockade may be a function of the effect of this class of drugs on the arterial baroreflex sensitivity for heart rate. However, our observations would indicate that -adrenoceptor antagonists are unlikely to attenuate any vascular and target organ damage in hypertensive patients arising from their increased BP variability. An effect of -adrenoceptor blockade on baroreflex sensitivity may be fundamental to the cardioprotective action of this class of drugs following myocardial infarction, or in mediating the medium- to long-term benefits of blockade in heart failure. If so, those patients whose baroreflex sensitivity does not improve following chronic -adrenoceptor blockade may be at highest risk for adverse outcome in these two conditions. This hypothesis merits prospective evaluation. References 1 Floras JS, Jones JV, Hassan MO, Sleight P. Effects of acute and chronic -adrenoceptor blockade on baroreflex sensitivity in humans. J Autonomic Nervous System 1988; 25: Vesalainen RK et al. Vagal cardiac activity in essential hypertension: the effects of metoprolol and ramipril. Am J Hypertens 1998; 11: Parati G et al. -adrenergic blocking treatment and 24- hour baroreflex sensitivity in essential hypertensive patients. Hypertension 1994; 23[part 2]: Lucini D, Pagani M, Malliani A. Improved baroreflex control of the heart rate with chronic beta-adrenergic blockade in mild hypertension. J Hypertens 1993; 11 (Suppl 5): S156 S Simon G, Kiowski W, Julius S. Effect of beta adrenoceptor antagonists on baroreceptor reflex sensitivity in hypertension. Clin Pharmacol 1997; 22: Watson RDS, Stallard TJ, Littler WA. Effects of -adrenoceptor antagonists on sino-aortic baroreflex sensi- 189
6 190 -blockade, baroreflex sensitivity, and BP tivity and blood pressure in hypertensive man. Clin Sci 1979; 57: Floras JS et al. Factors influencing blood pressure and heart rate variability in hypertensive humans. Hypertension 1988; 11: Floras JS et al. Consequences of impaired arterial baroreflexes in essential hypertension: effects on pressor responses, plasma noradrenaline and blood pressure variability. J Hypertens 1988; 6: Floras JS, Hassan MO, Jones JV, Sleight P. Cardioselective and nonselective beta-adrenoceptor blocking drugs in hypertension: a comparison of their effect on blood pressure during mental and physical activity. J Am Coll Cardiol 1986; 6: Parati G et al. Relationship of 24-hour blood pressure mean and variability to severity of target-organ damage in hypertension. J Hypertens 1987; 5: Verdecchia P et al. Ambulatory blood pressure. An independent predictor of prognosis in essential hypertension. Hypertension 1994; 24: Mancia G et al. Ambulatory blood pressure is superior to clinic blood pressure in predicting treatmentinduced regression of left ventricular hypertrophy. SAMPLE Study Group. Study on Ambulatory Monitoring of Blood Pressure and Lisinopril. Circulation 1997; 95: Frattola A et al. Prognostic value of 24-hour blood pressure variability. J Hypertens 1993; 11: Stott FD. The Oxford portable blood pressure transducer. In: Clement DL, ed. Blood pressure variability. MTP Press: Lancaster, UK, 1979, pp Ebert TJ. Captopril potentiates chronotropic baroreflex responses to carotid stimuli in humans. Hypertension 1985; 7: Giannattasio G et al. Investigation of reflexes from volume and baroreceptors during converting enzyme inhibition in humans. Am Heart J 1989; 117: Egan BM et al. Improved baroreflex sensitivity in elderly hypertensives on lisinopril is not explained by blood pressure reduction alone. J Hypertens 1993; 11: Tomiyana H et al. Effects of an ACE inhibitor and a calcium channel blocker on cardiovascular autonomic nervous system and carotid distensibility in patients with mild to moderate hypertension. Am J Hypertens 1998; 11: McLeay RAB, Stallard TJ, Watson RDS, Littler WA. The effect of nifedipine on arterial pressure and reflex cardiac control. Circulation 1983; 67: Young MA, Watson RDS, Littler WA. Baroreflex setting and sensitivity after acute and chronic nicardipine therapy. Clin Sci 1984; 66: Young MA, Watson RDS, Littler WA. Acute and chronic effects of the loop diuretic, piretanide, on baroreflex set point and sensitivity in hypertensive man. J Hypertens 1985; 3: Kailasam MT et al. Divergent effects of dihydropyridine and phenylalkylamine calcium channel antagonist classes on autonomic function in human hypertension. Hypertension 1995; 26: La Rovere et al, for the ATRAMI (Autonomic Tone and Reflexes After Myocardial Infarction) Investigators. Baroreflex sensitivity and heart-rate variability in prediction of total cardiac mortality after myocardial infarction. Lancet 1998; 351: Yusuf S et al. Beta blockade during and after myocardial infarction: An overview of the randomized trials. Progress in Cardiovasc Dis 1985; 27: Lechat P et al. Clinical effects of -adrenergic blockade in chronic heart failure. A meta-analysis of doubleblind, placebo-controlled, randomized trials. Circulation 1998; 98: Ichikawa M et al. Differential modulation of baroreceptor sensitivity by long-term antihypertensive treatment. Hypertension 1995; 26: Wallin BG, Sundlof G, Stromgren E, Aberg H. Sympathetic outflow to muscles during treatment of hypertension with metoprolol. Hypertension 1984; 6: Levy MN. Sympathetic-parasympathetic interactions in the heart. Circ Res 1971; 29: Kumagai K et al. Comparison of early and late start of antihypertensive agents and baroreceptor reflexes. Hypertension 1996; 27: Poller U et al. Age-dependent changes in cardiac muscarinic receptor function in healthy volunteers. JAm Coll Cardiol 1997; 29:
Slide notes: References:
1 2 3 Cut-off values for the definition of hypertension are systolic blood pressure (SBP) 135 and/or diastolic blood pressure (DBP) 85 mmhg for home blood pressure monitoring (HBPM) and daytime ambulatory
More informationAntihypertensive efficacy of olmesartan compared with other antihypertensive drugs
(2002) 16 (Suppl 2), S24 S28 2002 Nature Publishing Group All rights reserved 0950-9240/02 $25.00 www.nature.com/jhh compared with other antihypertensive drugs University Clinic Bonn, Department of Internal
More informationEffects of felodipine on haemodynamics and exercise capacity in patients with angina pectoris
Br. J. clin. Pharmac. (1987), 23, 391-396 Effects of felodipine on haemodynamics and exercise capacity in patients with angina pectoris J. V. SHERIDAN, P. THOMAS, P. A. ROUTLEDGE & D. J. SHERIDAN Departments
More informationShould beta blockers remain first-line drugs for hypertension?
1 de 6 03/11/2008 13:23 Should beta blockers remain first-line drugs for hypertension? Maros Elsik, Cardiologist, Department of Epidemiology and Preventive Medicine, Monash University and The Alfred Hospital,
More informationDRUG CLASSES BETA-ADRENOCEPTOR ANTAGONISTS (BETA-BLOCKERS)
DRUG CLASSES BETA-ADRENOCEPTOR ANTAGONISTS (BETA-BLOCKERS) Beta-blockers have been widely used in the management of angina, certain tachyarrhythmias and heart failure, as well as in hypertension. Examples
More informationCardiac Output MCQ. Professor of Cardiovascular Physiology. Cairo University 2007
Cardiac Output MCQ Abdel Moniem Ibrahim Ahmed, MD Professor of Cardiovascular Physiology Cairo University 2007 90- Guided by Ohm's law when : a- Cardiac output = 5.6 L/min. b- Systolic and diastolic BP
More informationBy Prof. Khaled El-Rabat
What is The Optimum? By Prof. Khaled El-Rabat Professor of Cardiology - Benha Faculty of Medicine HT. Introduction Despite major worldwide efforts over recent decades directed at diagnosing and treating
More informationThe Evolution To Treatment Of Hypertension With Advanced Formulation
The Evolution To Treatment Of Hypertension With Advanced Formulation Dr. Donald Ang MBChB (UK) FRCP (Edin) MD (UK) CCST Cardiology (UK) FESC (Europe) Consultant Cardiologist Island Hospital Penang High
More informationThe benefit of treatment with -blockers in heart failure is
Heart Rate and Cardiac Rhythm Relationships With Bisoprolol Benefit in Chronic Heart Failure in CIBIS II Trial Philippe Lechat, MD, PhD; Jean-Sébastien Hulot, MD; Sylvie Escolano, MD, PhD; Alain Mallet,
More informationOverview of the outcome trials in older patients with isolated systolic hypertension
Journal of Human Hypertension (1999) 13, 859 863 1999 Stockton Press. All rights reserved 0950-9240/99 $15.00 http://www.stockton-press.co.uk/jhh Overview of the outcome trials in older patients with isolated
More informationEffect of guanfacine on ambulatory. blood pressure and its variability in elderly patients with essential hypertension
Br. J. clin. Pharmac. (1987), 23, 397-401 Effect of guanfacine on ambulatory. blood pressure and its variability in elderly patients with essential hypertension A. G. DUPONT, P. VANDERNIEPEN & R. 0. SIX
More informationLab Period: Name: Physiology Chapter 14 Blood Flow and Blood Pressure, Plus Fun Review Study Guide
Lab Period: Name: Physiology Chapter 14 Blood Flow and Blood Pressure, Plus Fun Review Study Guide Main Idea: The function of the circulatory system is to maintain adequate blood flow to all tissues. Clinical
More informationTherefore MAP=CO x TPR = HR x SV x TPR
Regulation of MAP Flow = pressure gradient resistance CO = MAP TPR Therefore MAP=CO x TPR = HR x SV x TPR TPR is the total peripheral resistance: this is the combined resistance of all blood vessels (remember
More informationChapter 10. Learning Objectives. Learning Objectives 9/11/2012. Congestive Heart Failure
Chapter 10 Congestive Heart Failure Learning Objectives Explain concept of polypharmacy in treatment of congestive heart failure Explain function of diuretics Learning Objectives Discuss drugs used for
More informationThe problem of uncontrolled hypertension
(2002) 16, S3 S8 2002 Nature Publishing Group All rights reserved 0950-9240/02 $25.00 www.nature.com/jhh The problem of uncontrolled hypertension Department of Public Health and Clinical Medicine, Norrlands
More informationEvidence of Baroreflex Activation Therapy s Mechanism of Action
Evidence of Baroreflex Activation Therapy s Mechanism of Action Edoardo Gronda, MD, FESC Heart Failure Research Center IRCCS MultiMedica Cardiovascular Department Sesto S. Giovanni (Milano) Italy Agenda
More informationeffects of intravenous labetalol
Pharmacological basis for antihypertensive effects of intravenous labetalol D. A. RICHARDS,' B. N. C. PRICHARD, A. J. BOAKES, J. TUCKMAN, AND E. J. KNIGHT2 From the Department of Clinical Pharmacology,
More informationANTIHYPERTENSIVE DRUG THERAPY IN CONSIDERATION OF CIRCADIAN BLOOD PRESSURE VARIATION*
Progress in Clinical Medicine 1 ANTIHYPERTENSIVE DRUG THERAPY IN CONSIDERATION OF CIRCADIAN BLOOD PRESSURE VARIATION* Keishi ABE** Asian Med. J. 44(2): 83 90, 2001 Abstract: J-MUBA was a large-scale clinical
More informationHow well do office and exercise blood pressures predict sustained hypertension? A Dundee Step Test Study
(2000) 14, 429 433 2000 Macmillan Publishers Ltd All rights reserved 0950-9240/00 $15.00 www.nature.com/jhh ORIGINAL ARTICLE How well do office and exercise blood pressures predict sustained hypertension?
More informationAntihypertensive drugs SUMMARY Made by: Lama Shatat
Antihypertensive drugs SUMMARY Made by: Lama Shatat Diuretic Thiazide diuretics The loop diuretics Potassium-sparing Diuretics *Hydrochlorothiazide *Chlorthalidone *Furosemide *Torsemide *Bumetanide Aldosterone
More informationDESPITE widespread use of beta-adrenergic receptor
Sympathetic Outflow to Muscles During Treatment of Hypertension with Metoprolol B. GUNNAR WALLIN, GORAN SUNDLOF, ERLAND STROMGREN, AND HANS ABERG SUMMARY Microelectrode recordings of multiunit sympathetic
More informationThe CARI Guidelines Caring for Australasians with Renal Impairment. Blood Pressure Control role of specific antihypertensives
Blood Pressure Control role of specific antihypertensives Date written: May 2005 Final submission: October 2005 Author: Adrian Gillian GUIDELINES a. Regimens that include angiotensin-converting enzyme
More informationHYPERTENSION: Sustained elevation of arterial blood pressure above normal o Systolic 140 mm Hg and/or o Diastolic 90 mm Hg
Lecture 39 Anti-Hypertensives B-Rod BLOOD PRESSURE: Systolic / Diastolic NORMAL: 120/80 Systolic = measure of pressure as heart is beating Diastolic = measure of pressure while heart is at rest between
More informationAngina pectoris due to coronary atherosclerosis : Atenolol is indicated for the long term management of patients with angina pectoris.
Lonet Tablet Description Lonet contains Atenolol, a synthetic β1 selective (cardioselective) adrenoreceptor blocking agent without membrane stabilising or intrinsic sympathomimetic (partial agonist) activity.
More informationAntihypertensive Trial Design ALLHAT
1 U.S. Department of Health and Human Services Major Outcomes in High Risk Hypertensive Patients Randomized to Angiotensin-Converting Enzyme Inhibitor or Calcium Channel Blocker vs Diuretic National Institutes
More informationYounger adults with a family history of premature artherosclerotic disease should have their cardiovascular risk factors measured.
Appendix 2A - Guidance on Management of Hypertension Measurement of blood pressure All adults from 40 years should have blood pressure measured as part of opportunistic cardiovascular risk assessment.
More informationHypertension. Penny Mosley MRPharmS
Hypertension Penny Mosley MRPharmS Outline of presentation Introduction to hypertension Physiological control of arterial blood pressure What determines our bp? What determines the heart rate? What determines
More informationCASE 13. What neural and humoral pathways regulate arterial pressure? What are two effects of angiotensin II?
CASE 13 A 57-year-old man with long-standing diabetes mellitus and newly diagnosed hypertension presents to his primary care physician for follow-up. The patient has been trying to alter his dietary habits
More informationβ adrenergic blockade, a renal perspective Prof S O McLigeyo
β adrenergic blockade, a renal perspective Prof S O McLigeyo Carvedilol Third generation β blocker (both β 1 and β 2 ) Possesses α 1 adrenergic blocking properties. β: α blocking ratio 7:1 to 3:1 Antioxidant
More informationThe effects of oral nitrendipine and propranolol, alone and in combination, on hypertensive patients with special reference to
Br. J. clin. Pharmac. (1986), 22, 463-467 The effects of oral nitrendipine and propranolol, alone and in combination, on hypertensive patients with special reference to AV conduction M. B. MALTZ, D. W.
More informationPharmacological Treatment for Chronic Heart Failure. Dr Elaine Chau HK Sanatorium & Hospital, Hong Kong 3 August 2014
Pharmacological Treatment for Chronic Heart Failure Dr Elaine Chau HK Sanatorium & Hospital, Hong Kong 3 August 2014 1 ACC/AHA 2005 guideline update for Diagnosis & management of CHF in the Adult -SA Hunt
More informationChanges in Blood Pressure and Vascular Physiology: Markers for Cardiovascular Disease
...SYMPOSIUM PROCEEDINGS... Changes in Blood Pressure and Vascular Physiology: Markers for Cardiovascular Disease Based on a presentation by Joseph L. Izzo, Jr., MD Presentation Summary Changes in systolic
More informationResponses to Changes in Posture QUESTIONS. Case PHYSIOLOGY CASES AND PROBLEMS
64 PHYSIOLOGY CASES AND PROBLEMS Case 12 Responses to Changes in Posture Joslin Chambers is a 27-year-old assistant manager at a discount department store. One morning, she awakened from a deep sleep and
More informationManagement of Hypertension
Clinical Practice Guidelines Management of Hypertension Definition and classification of blood pressure levels (mmhg) Category Systolic Diastolic Normal
More informationA double-blind comparison of bisoprolol and atenolol in patients with essential hypertension
QJ Med 995; 88:55-5 A double-blind comparison of bisoprolol and atenolol in patients with essential hypertension N.M. WHEELDON, T.M. MacDONALD, N. PRASAD, D. MACLEAN, L. PEEBLES and D.G. McDEVITT From
More informationambulatory blood pressure during long term dual chamber atrioventricular synchronous (DDD) and ventricular demand (VVI) pacing
Br Heart J 1987;58:34-9 A comparison of symptoms and intra-arterial ambulatory blood pressure during long term dual chamber atrioventricular synchronous (DDD) and ventricular demand (VVI) pacing N A BOON,*
More informationCombination therapy Giuseppe M.C. Rosano, MD, PhD, MSc, FESC, FHFA St George s Hospitals NHS Trust University of London
Combination therapy Giuseppe M.C. Rosano, MD, PhD, MSc, FESC, FHFA St George s Hospitals NHS Trust University of London KCS Congress: Impact through collaboration CONTACT: Tel. +254 735 833 803 Email:
More informationMetoprolol Succinate SelokenZOC
Metoprolol Succinate SelokenZOC Blood Pressure Control and Far Beyond Mohamed Abdel Ghany World Health Organization - Noncommunicable Diseases (NCD) Country Profiles, 2014. 1 Death Rates From Ischemic
More information- Dr Alia Shatnawi. 1 P a g e
- 1 مها أبو عجمية - - - Dr Alia Shatnawi 1 P a g e A Skippable Intr0 Blood pressure normally decreases during the night. Absence of this phenomenon is called (nondipping) Wikipedia: Circadian rhythm....
More informationPrevention of Heart Failure: What s New with Hypertension
Prevention of Heart Failure: What s New with Hypertension Ali AlMasood Prince Sultan Cardiac Center Riyadh 3ed Saudi Heart Failure conference, Jeddah, 13 December 2014 Background 20-30% of Saudi adults
More informationThe Systemic Effect Of Topical Timolol On Some Cardiovascular Parameters In Owerri Municipality
ISPUB.COM The Internet Journal of Third World Medicine Volume 5 Number 1 The Systemic Effect Of Topical Timolol On Some Cardiovascular Parameters In Owerri Municipality G Oze, M Emegwamuo, P Eleanya, H
More informationAmbulatory Blood Pressure Monitoring Clinical Practice Recommendations
Acta Medica Marisiensis 2016;62(3):350-355 DOI: 10.1515/amma-2016-0038 UPDATE Ambulatory Blood Pressure Monitoring Clinical Practice Recommendations Mako Katalin *, Ureche Corina, Jeremias Zsuzsanna University
More informationDRUG UTILIZATION PATTERNS OF ANTIHYPERTENSIVES IN VARIOUS WARDS IN A TERTIARY CARE HOSPITAL IN TAMILNADU
Original Article DRUG UTILIZATION PATTERNS OF ANTIHYPERTENSIVES IN VARIOUS WARDS IN A TERTIARY CARE HOSPITAL IN TAMILNADU V.Gowri 1, K.Punnagai, K.Vijaybabu 3, Dr.Darling Chellathai 4 1 Assistant Professor
More informationCentral Pressures and Prehypertension
Central Pressures and Prehypertension Charalambos Vlachopoulos Associate Professor of Cardiology 1 st Cardiology Dept Athens Medical School Central Pressures and Prehypertension Charalambos Vlachopoulos
More informationLarge therapeutic studies in elderly patients with hypertension
(2002) 16 (Suppl 1), S38 S43 2002 Nature Publishing Group All rights reserved 0950-9240/02 $25.00 www.nature.com/jhh Large therapeutic studies in elderly patients with hypertension Centro Clinico Profesional
More informationBlood Pressure Regulation. Faisal I. Mohammed, MD,PhD
Blood Pressure Regulation Faisal I. Mohammed, MD,PhD 1 Objectives Outline the short term and long term regulators of BP Know how baroreceptors and chemoreceptors work Know function of the atrial reflex.
More informationTreating Hypertension in Individuals with Diabetes
Treating Hypertension in Individuals with Diabetes Copyright 2017 by Sea Courses Inc. All rights reserved. No part of this document may be reproduced, copied, stored, or transmitted in any form or by any
More informationManagement of the coronary patient in Roberto Ferrari
Management of the coronary patient in 2011 Roberto Ferrari What is new in treatment of stable CAD? In the era of interventional cardiology, is chronic stable angina a rare disease? Stable angina pectoris
More informationPrognostic significance of blood pressure measured on rising
(2001) 15, 413 417 2001 Nature Publishing Group All rights reserved 0950-9240/01 $15.00 www.nature.com/jhh ORIGINAL ARTICLE Prognostic significance of blood pressure measured on rising P Gosse, C Cipriano,
More informationHRV in Diabetes and Other Disorders
HRV in Diabetes and Other Disorders Roy Freeman, MD Center for Autonomic and Peripheral Nerve Disorders Beth Israel Deaconess Medical Center Harvard Medical School Control Propranolol Atropine Wheeler
More information47 Hypertension in Elderly
47 Hypertension in Elderly YOU DO NOT HEAL OLD AGE; YOU PROTECT IT; YOU PROMOTE IT; YOU EXTEND IT Sir James Sterling Ross Abstract: The prevalence of hypertension rises with age and the complications secondary
More informationReducing proteinuria
Date written: May 2005 Final submission: October 2005 Author: Adrian Gillin Reducing proteinuria GUIDELINES a. The beneficial effect of treatment regimens that include angiotensinconverting enzyme inhibitors
More informationImplanting a baroreceptor stimulation device for resistant hypertension
NATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE Interventional procedure consultation document Implanting a baroreceptor stimulation device for resistant hypertension Hypertension (or high blood pressure)
More informationHypertension: What s new since JNC 7. Harold M. Szerlip, MD, FACP, FCCP, FASN, FNKF
Hypertension: What s new since JNC 7 Harold M. Szerlip, MD, FACP, FCCP, FASN, FNKF Disclosures Spectral Diagnostics Site investigator Eli Lilly Site investigator ACP IM ITE writing committee NBME Step
More informationHow clinically important are the results of the large trials in hypertension?
How clinically important are the results of the large trials in hypertension? Stéphane LAURENT, MD, PhD, FESC Pharmacology Department and PARCC / INSERM U970 Hôpital Européen Georges Pompidou, Université
More informationRole of Sympathetic Nervous System in Hypertension
Role of Sympathetic Nervous System in Hypertension BP = CO x PVR SV HR DEFENSE REACTION Suppressed vagal activity Increased sympathetic activity to heart, veins, kidneys, splachnic region, skin Skeletal
More informationEchocardiographic definition of left ventricular hypertrophy in the hypertensive: which method of indexation of left ventricular mass?
Journal of Human Hypertension (1999) 13, 505 509 1999 Stockton Press. All rights reserved 0950-9240/99 $12.00 http://www.stockton-press.co.uk/jhh ORIGINAL ARTICLE Echocardiographic definition of left ventricular
More information...SELECTED ABSTRACTS...
The following abstracts, from peer-reviewed journals containing literature on vascular compliance and hypertension, were selected for their relevance to this conference and to a managed care perspective.
More informationPrevalence of left ventricular hypertrophy in a hypertensive population
European Heart Journal (1996) 17, 143-149 Prevalence of left ventricular hypertrophy in a hypertensive population J. Tingleff, M. Munch, T. J. Jakobsen, C. Torp-Pedersen, M. E. Olsen, K. H. Jensen, T.
More informationHeart Failure Treatments
Heart Failure Treatments Past & Present www.philippelefevre.com Background Background Chronic heart failure Drugs Mechanical Electrical Background Chronic heart failure Drugs Mechanical Electrical Sudden
More informationIntroductory Clinical Pharmacology Chapter 41 Antihypertensive Drugs
Introductory Clinical Pharmacology Chapter 41 Antihypertensive Drugs Blood Pressure Normal = sys
More informationHypertensives Emergency and Urgency
Hypertensives Emergency and Urgency Budi Yuli Setianto Cardiology Divisision Department of Internal Medicine Faculty of Medicine UGM Sardjito Hospital Yogyakarta Background USA: Hypertension is 30% of
More information(D) (E) (F) 6. The extrasystolic beat would produce (A) increased pulse pressure because contractility. is increased. increased
Review Test 1. A 53-year-old woman is found, by arteriography, to have 5% narrowing of her left renal artery. What is the expected change in blood flow through the stenotic artery? Decrease to 1 2 Decrease
More informationHypertension in the Elderly. John Puxty Division of Geriatrics Center for Studies in Aging and Health, Providence Care
Hypertension in the Elderly John Puxty Division of Geriatrics Center for Studies in Aging and Health, Providence Care Learning Objectives Review evidence for treatment of hypertension in elderly Consider
More informationHypertension. Most important public health problem in developed countries
Hypertension Strategy for Continued Success in Treatment for the 21st Century November 15, 2005 Arnold B. Meshkov, M.D. Associate Professor of Medicine Temple University School of Medicine Philadelphia,
More informationantagonist, amlodipine
Br. J. clin. Pharmac. (1989), 27, 359-365 24 h blood pressure control with the once daily calcium antagonist, amlodipine M.. HBR, G. BRGDN,. AL-KHAWAJA &. B. RAFTRY The Cardiology Department and the Division
More informationIncreased forearm vascular resistance after dopamine blockade
Br. J. clin. Pharnac. (1984), 17, 373-378 Increased forearm vascular resistance after dopamine blockade D. MANNERING, E.D. BENNE7T, N. MEHTA & F. KEMP Department of Medicine 1, St George's Hospital Medical
More informationProperties of Pressure
OBJECTIVES Overview Relationship between pressure and flow Understand the differences between series and parallel circuits Cardiac output and its distribution Cardiac function Control of blood pressure
More informationTEACH Lesson Plan Manual for Herlihy s The Human Body in Health and Illness 5 th edition
TEACH Lesson Plan Manual for Herlihy s The Human Body in Health and Illness 5 th edition Chapter 17 Function of the Heart Lesson 17.1 Function of the Heart 1. Define cardiac cycle with respect to systole
More informationMorning Hypertension: A Pitfall of Current Hypertensive Management
Review Article Hypertension: A Pitfall of Current Hypertensive Management JMAJ 48(5): 234 240, 2005 Kazuomi Kario* 1 Abstract has recently attracted more attention because of the close relation between
More informationTodd S. Perlstein, MD FIFTH ANNUAL SYMPOSIUM
Todd S. Perlstein, MD FIFTH ANNUAL SYMPOSIUM Faculty Disclosure I have no financial interest to disclose No off-label use of medications will be discussed FIFTH ANNUAL SYMPOSIUM Recognize changes between
More informationThe Exercise Pressor Reflex
The Exercise Pressor Reflex Dr. James P. Fisher School of Sport, Exercise & Rehabilitation Sciences College of Life & Environmental Sciences University of Birmingham, UK Copenhagen, 2018 Based on work
More informationRegression of Electrocardiographic Left Ventricular Hypertrophy by Losartan Versus Atenolol
Regression of Electrocardiographic Left Ventricular Hypertrophy by Losartan Versus Atenolol The Losartan Intervention For Endpoint reduction in hypertension (LIFE) Study Peter M. Okin, MD; Richard B. Devereux,
More informationPreventing the cardiovascular complications of hypertension
European Heart Journal Supplements (2004) 6 (Supplement H), H37 H42 Preventing the cardiovascular complications of hypertension Peter Trenkwalder* Department of Internal Medicine, Starnberg Hospital, Ludwig
More informationHow Low Do We Go? Update on Hypertension
How Low Do We Go? Update on Beth L. Abramson, MD, FRCPC, FACC As presented at the University of Toronto s Saturday at the University Session (September 2003) Arecent World Health Organization report states
More informationAntihypertensives. Antihypertensive Classes. RAAS Inhibitors. Renin-Angiotensin Cascade. Angiotensin Receptors. Approaches to Hypertension Treatment
Approaches to Hypertension Treatment Antihypertensives Inhibit Sympathetic impulses Inhibit contractility Inhibit heart rate Inhibit vasoconstriction Inhibit smooth muscle function Inhibit RAAS Inhibit
More informationHYPERTENSION IN THE ELDERLY A BALANCED APPROACH. Barry Goldlist October 31, 2014
HYPERTENSION IN THE ELDERLY A BALANCED APPROACH Barry Goldlist October 31, 2014 DISCLOSURE I have not accepted any money for myself from any pharmaceutical company in the 21 st century I have accepted
More informationcombination (97 ± 8 beats min-'; 65 ± 4 beats cardiac output may be balanced by the vasodilatation
Br J clin Pharmac 1994; 37: 45-51 An assessment of lacidipine and atenolol in mild to moderate hypertension D. LYONS, G. FOWLER, J. WEBSTER, S. T. HALL' & J. C. PETRIE Clinical Pharmacology Unit, Department
More informationCan Arterial Stiffness Be Reversed? And If So, What Are the Benefits?
...SYMPOSIUM PROCEEDINGS... Can Arterial Stiffness Be Reversed? And If So, What Are the Benefits? Based on a presentation by Michel E. Safar, MD Presentation Summary Systolic and diastolic blood pressure
More informationBIPN100 F15 Human Physiol I (Kristan) Lecture 14 Cardiovascular control mechanisms p. 1
BIPN100 F15 Human Physiol I (Kristan) Lecture 14 Cardiovascular control mechanisms p. 1 Terms you should understand: hemorrhage, intrinsic and extrinsic mechanisms, anoxia, myocardial contractility, residual
More informationHYPERTENSION IN EMERGENCY MEDICINE Michael Jay Bresler, M.D., FACEP
HYPERTENSION IN EMERGENCY MEDICINE Michael Jay Bresler, M.D., FACEP What is normal blood pressure? Prehypertension 130-139/80-90 Compared with normal BP Double the risk for developing hypertension. Lifestyle
More informationCirculation. Blood Pressure and Antihypertensive Medications. Venous Return. Arterial flow. Regulation of Cardiac Output.
Circulation Blood Pressure and Antihypertensive Medications Two systems Pulmonary (low pressure) Systemic (high pressure) Aorta 120 mmhg Large arteries 110 mmhg Arterioles 40 mmhg Arteriolar capillaries
More informationJournal of the American College of Cardiology Vol. 38, No. 5, by the American College of Cardiology ISSN /01/$20.
Journal of the American College of Cardiology Vol. 38, No. 5, 2001 2001 by the American College of Cardiology ISSN 0735-1097/01/$20.00 Published by Elsevier Science Inc. PII S0735-1097(01)01577-7 Lack
More informationEgyptian Hypertension Guidelines
Egyptian Hypertension Guidelines 2014 Egyptian Hypertension Guidelines Dalia R. ElRemissy, MD Lecturer of Cardiovascular Medicine Cairo University Why Egyptian Guidelines? Guidelines developed for rich
More informationEffects of a perindopril-based blood pressure lowering regimen on cardiac outcomes among patients with cerebrovascular disease
European Heart Journal (2003) 24, 475 484 Effects of a perindopril-based blood pressure lowering regimen on cardiac outcomes among patients with cerebrovascular disease PROGRESS Collaborative Group 1*
More informationRISE, FALL AND RESURRECTION OF RENAL DENERVATION. Michael A. Weber, MD State University of New York Downstate College of Medicine
RISE, FALL AND RESURRECTION OF RENAL DENERVATION Michael A. Weber, MD State University of New York Downstate College of Medicine Michael Weber, Disclosures Research/Trial Commitments and Consulting: Boston
More informationΜη φαρμακευτική θεραπεία στην Χρόνια Καρδιακή Ανεπάρκεια Νεότερες συσκευές. Ξυδώνας Σωτήριος, MD, PhD, FESC
ΠΑΝΕΛΛΗΝΙΑ ΣΕΜΙΝΑΡΙΑ ΟΜΑΔΩΝ ΕΡΓΑΣΙΑΣ 2017 ΟΜΑΔΑ ΕΡΓΑΣΙΑΣ ΚΑΡΔΙΑΚΗΣ ΑΝΕΠΑΡΚΕΙΑΣ Μη φαρμακευτική θεραπεία στην Χρόνια Καρδιακή Ανεπάρκεια Νεότερες συσκευές Ξυδώνας Σωτήριος, MD, PhD, FESC Καρδιολογικό Τμήμα,
More informationBlood Pressure Response Under Chronic Antihypertensive Drug Therapy
Journal of the American College of Cardiology Vol. 53, No. 5, 29 29 by the American College of Cardiology Foundation ISSN 735-197/9/$36. Published by Elsevier Inc. doi:1.116/j.jacc.28.9.46 Hypertension
More informationAntihypertensive Agents Part-2. Assistant Prof. Dr. Najlaa Saadi PhD Pharmacology Faculty of Pharmacy University of Philadelphia
Antihypertensive Agents Part-2 Assistant Prof. Dr. Najlaa Saadi PhD Pharmacology Faculty of Pharmacy University of Philadelphia Agents that block production or action of angiotensin Angiotensin-converting
More informationCardiovascular drugs
chapter 13 Cardiovascular drugs Cardiovascular drugs act on the heart or blood vessels to control the cardiovascular system. They are used to treat a variety of conditions from hypertension to chronic
More informationHigh-dose monotherapy vs low-dose combination therapy of calcium channel blockers and angiotensin receptor blockers in mild to moderate hypertension
(2005) 19, 491 496 & 2005 Nature Publishing Group All rights reserved 0950-9240/05 $30.00 www.nature.com/jhh ORIGINAL ARTICLE High-dose monotherapy vs low-dose combination therapy of calcium channel blockers
More informationCitation Acta medica Nagasakiensia. 1997, 42
NAOSITE: Nagasaki University's Ac Title Age and Gender Differences in White Author(s) Li, Zhang Ting Citation Acta medica Nagasakiensia. 1997, 42 Issue Date 1997-12-20 URL http://hdl.handle.net/10069/16086
More informationInfluence of Age, Hypertension or Myocardial Infarction on Cardiovascular Responses to Changes in Body Position
Influence of Age, Hypertension or Myocardial Infarction on Cardiovascular Responses to Changes in Body Position A population-based study in 30-, 50- and 60-year-old men BY ANNA HOFSTEN UPPSALA UNIVERSITY
More information1. Despite the plethora of new ACE-inhibitors they offer little advantage over the earlier products captopril and enalapril.
SUMMARY 1. Despite the plethora of new ACE-inhibitors they offer little advantage over the earlier products captopril and enalapril. 2. While diuretics and beta-blockers remain first-line antihypertensive
More informationSummary of recommendations
Summary of recommendations Measuring blood pressure (BP) Use the recommended technique at every BP reading to ensure accurate measurements and avoid common errs. Pay particular attention to the following:
More informationEffects of Renin-Angiotensin System blockade on arterial stiffness and function. Gérard M. LONDON Manhès Hospital Paris, France
Effects of Renin-Angiotensin System blockade on arterial stiffness and function Gérard M. LONDON Manhès Hospital Paris, France Determinants of vascular overload (afterload) on the heart Peripheral Resistance
More informationCombination Therapy for Hypertension
Combination Therapy for Hypertension Se-Joong Rim, MD Cardiology Division, Yonsei University College of Medicine, Seoul, Korea Goals of Therapy Reduce CVD and renal morbidity and mortality. Treat to BP
More informationIN VIVO ASSESSMENT OF CENTRAL AND PERIPHERAL HEMODYNAMIC IMPACT OF THE C-PULSE SYSTEM
IN VIVO ASSESSMENT OF CENTRAL AND PERIPHERAL HEMODYNAMIC IMPACT OF THE C-PULSE SYSTEM Francisco Javier Londono Hoyos, PhD; Dimitrios Georgakopoulos, PhD; Oliver Fey; Dori Jones, MS; Christian Schlensak,
More informationClinical Updates in the Treatment of Hypertension JNC 7 vs. JNC 8. Lauren Thomas, PharmD PGY1 Pharmacy Practice Resident South Pointe Hospital
Clinical Updates in the Treatment of Hypertension JNC 7 vs. JNC 8 Lauren Thomas, PharmD PGY1 Pharmacy Practice Resident South Pointe Hospital Objectives Review the Eighth Joint National Committee (JNC
More informationHypertension and ischemic heart disease
Available online at www.sciencedirect.com journal homepage: www.elsevier.com/locate/crvasa Education in Cardiology Hypertension and ischemic heart disease Jindřich Špinar Clinic of Internal Medicine and
More information